-
Ma King W, Green EL, Raij L. Cardiovascular risk factors inchronic renal failure and hemodialysis populations. Am J of Kidney diseases 1992; 19(6): 505-15.
-
Grundy SM. Cholesterol and coronary heart disease: A new era. JAMA 1986; 256: 2849-58.
-
Majumdar A, Wheeler DC. Lipid abnormalities in renal disease .J.R. Soc Med 2000; 93: 178-82.
-
Gokal RJ. Outcome in patients on continuous ambulatory peritoneal dialysis and hemodialysis.Lancet 1987; 14: 1105-9.
-
Attman PO., Alauporic P. Lipid abnormalities in chronic renalin sufficiency. Kidney Int 1991; 39 (31): 16-23.
-
Crook ED, Thallapureddy A, Migdal S, FlacJM,Greene EL, Salahudeen A, et.al., Lipid abnormalities and renal disease. Is Dyslipidemia a predictor of progression of renal disease? Am J Med Sci 2003;325:340-348.
-
David CW, Ravinder SC. Oxidation of LDL by mesangial cells may promote glomerular injury. Kidney Int 1994; 45: 1628-36
-
Monzoni G, et al. “Lipoprotein abnormalities in chronic renal failure and dialysis patients”. Blood Purif, 1996; 14(3) : 262- 72.
-
MarianoSenti,etal.“Lipoprotienabnormalitiesinhyperlipidemicandnormolipidemicmenonhemodialysiswithchronicrenalfailure”.KidneyInt,1992;41:1394-1399.
-
Brunzell JD., et al. “Prevalence of serum lipid abnormalities in chronichemodialysis”. Metabolism, 1977; 26: 903-910.
-
Alam SM, AK Bhatt. “Abnormal lipoprotien in uremic patients treated conservatively and by maintenance hemodialysis”. JAPI, 1991;39: 170-172.
-
Marian Morena, et al. “Protective effects of HDL against oxidative stressare impaired in hemodialysis patients”. N.D Transplant, 2000;15: 389-395.
-
Pedro Botet J. “When to treat dyslipidemia of patients with CRF on hemodialysis? A need to define specific guidelines”. N.D. Transplant,1996; 11: 308-313.
-
Wheeler DC. “Should hyperlipidemia in dialysis patients be treated?. N.D. Transplant, 1997;12: 19-21.
-
Kalra OP, Khaira A, Gambhir JK, Agarwal S, Bhargava SK. Lipoprotein(a) in Chronic Renal Failure: Effect of Maintenance Hemodialysis. HemodialInt 2003; 7(4): 326-33.
